Fidelity Said to Push Endo Health to Consider a Sale

Endo Health Solutions Inc.’s largest shareholder, Fidelity Investments, is pushing the drugmaker to consider a sale after disappointing forecasts, three people with knowledge of the situation said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.